IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,415,984 | +24.8% | 119,400 | +12.9% | 0.21% | +27.0% |
| Q2 2023 | $4,339,661 | +13.3% | 105,768 | +22.1% | 0.16% | +8.7% |
| Q3 2022 | $3,831,000 | -9.9% | 86,602 | -24.6% | 0.15% | -18.5% |
| Q2 2022 | $4,253,000 | +4.5% | 114,857 | +4.6% | 0.18% | +5.1% |
| Q1 2022 | $4,068,000 | +10.9% | 109,827 | -8.9% | 0.18% | -23.9% |
| Q4 2021 | $3,667,000 | +47.3% | 120,500 | +93.1% | 0.23% | -4.2% |
| Q2 2021 | $2,489,000 | +726.9% | 62,400 | +885.2% | 0.24% | +300.0% |
| Q3 2020 | $301,000 | – | 6,334 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |